+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "FDA Warning Letter"

Medical Device Process Validation Training for Professionals - Webinar (Recorded) - Product Thumbnail Image

Medical Device Process Validation Training for Professionals - Webinar (Recorded)

  • Webinar
  • March 2023
  • 90 Minutes
  • Global
From
Promoting and Advertising Dietary Supplements in Compliance with FDA and FTC Regulations - Webinar (Recorded) - Product Thumbnail Image

Promoting and Advertising Dietary Supplements in Compliance with FDA and FTC Regulations - Webinar (Recorded)

  • Webinar
  • December 2022
  • 120 Minutes
  • Global
From
6-Hour Virtual Seminar on Audit like the FDA - Webinar (Recorded) - Product Thumbnail Image

6-Hour Virtual Seminar on Audit like the FDA - Webinar (Recorded)

  • Webinar
  • August 2022
  • 360 Minutes
  • Global
From
Ensuring Your Site Is Ready For An Fda Inspection - Webinar (Recorded) - Product Thumbnail Image

Ensuring Your Site Is Ready For An Fda Inspection - Webinar (Recorded)

  • Webinar
  • June 2022
  • 90 Minutes
  • Global
From
21 CFR Part 111 - Current FDA 483 Observations and Warning Letters Review - State of the Dietary Supplement Industry - Webinar (Recorded) - Product Thumbnail Image

21 CFR Part 111 - Current FDA 483 Observations and Warning Letters Review - State of the Dietary Supplement Industry - Webinar (Recorded)

  • Webinar
  • February 2022
  • 60 Minutes
  • Global
Lifecycle Management of Analytical Methods and Procedures according to new USP and ICH Guidelines (Recorded) - Product Thumbnail Image

Lifecycle Management of Analytical Methods and Procedures according to new USP and ICH Guidelines (Recorded)

  • Training
  • December 2021
  • 2 Days
  • Global
From
Essentials Of USP Microbiology - Reading Between the Lines of the USP General and Information Microbiology Chapters (Recorded) - Product Thumbnail Image

Essentials Of USP Microbiology - Reading Between the Lines of the USP General and Information Microbiology Chapters (Recorded)

  • Training
  • October 2021
  • 2 Days
  • Global
From
Good Documentation Practice and Record Keeping Regulations (FDA & EMA) - Webinar (Recorded) - Product Thumbnail Image

Good Documentation Practice and Record Keeping Regulations (FDA & EMA) - Webinar (Recorded)

  • Webinar
  • March 2019
  • 60 Minutes
  • Global
Establishing a Robust Data Integrity Program - Webinar (Recorded) - Product Thumbnail Image

Establishing a Robust Data Integrity Program - Webinar (Recorded)

  • Webinar
  • February 2019
  • 90 Minutes
  • Global
GMP Laboratory Training - Pack of 7 Courses - Product Thumbnail Image

GMP Laboratory Training - Pack of 7 Courses

  • Training
  • 12 Hours
  • Global
How to Prevent cGMP Violations & Warning letters - Training for Pharma Manufacturing - Product Thumbnail Image

How to Prevent cGMP Violations & Warning letters - Training for Pharma Manufacturing

  • Training
  • 8 Hours
  • Global
FDA Regulatory Inspection and Audit Training: Pack of 6 Training Courses - Product Thumbnail Image

FDA Regulatory Inspection and Audit Training: Pack of 6 Training Courses

  • Training
  • 7 Hours
  • Global
Fundamentals of Process Validation - Product Thumbnail Image

Fundamentals of Process Validation

  • Training
  • 80 Minutes
  • Global
21 CFR Part 111 - Current FDA 483 Observations and Warning Letters Review - Product Thumbnail Image

21 CFR Part 111 - Current FDA 483 Observations and Warning Letters Review

  • Training
  • 60 Minutes
  • Global
Using ICH Q9 and Recent FDA Comments as the Foundation for the Planning, Development and Execution of Risk-Based Cleaning Validation Studies - Product Thumbnail Image

Using ICH Q9 and Recent FDA Comments as the Foundation for the Planning, Development and Execution of Risk-Based Cleaning Validation Studies

  • Training
  • 90 Minutes
  • Global
Responding to FDA 483s and FDA Warning Letters - Best Practices - Product Thumbnail Image

Responding to FDA 483s and FDA Warning Letters - Best Practices

  • Training
  • 120 Minutes
  • Global
How to successfully audit software systems, and thereby avoid having FDA write software-related 483's and warning letters - Product Thumbnail Image

How to successfully audit software systems, and thereby avoid having FDA write software-related 483's and warning letters

  • Training
  • 60 Minutes
  • Global
What will FDA expect and request from your firm during Design Control portions of Inspections? - Product Thumbnail Image

What will FDA expect and request from your firm during Design Control portions of Inspections?

  • Training
  • 60 Minutes
  • Global
Equipment Qualification and Process Validation - Product Thumbnail Image

Equipment Qualification and Process Validation

  • Training
  • 90 Minutes
  • Global
Executive Exposure under Strict Liability Doctrine in FDA Enforcement - Product Thumbnail Image

Executive Exposure under Strict Liability Doctrine in FDA Enforcement

  • Training
  • 90 Minutes
  • Global
Loading Indicator

The FDA Warning Letter market within the context of Pharmaceutical Manufacturing is a market that focuses on the enforcement of regulations and standards set by the U.S. Food and Drug Administration (FDA). Companies in this market are responsible for ensuring that their products meet the FDA's requirements for safety, efficacy, and quality. Companies must also comply with the FDA's Good Manufacturing Practices (GMPs) and other regulations. Companies that fail to meet these standards may receive a warning letter from the FDA, which can result in fines, product recalls, or other penalties. Companies in this market must also be aware of the latest developments in the industry, such as new regulations or changes to existing regulations. Some companies in the FDA Warning Letter market include Pfizer, Merck, Johnson & Johnson, Novartis, and GlaxoSmithKline. Show Less Read more